HSG Holding Ltd Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001470766

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedConsumer Tilt how tags are computed

Q2 2026 · 21 positions · Total reported value $1.24B · Top-10 concentration 96.2% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 19.0% · 0 new · 2 cut · 2 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 99.8% — share of the book that differs from index weights (higher = more active) · ranking

In its Q2 2026 13F filing, HSG Holding Ltd disclosed 21 equity positions with a combined reported value of $1.24B. The filing implies a focused portfolio: its ten largest positions account for 96.2% of reported value. HoldingsHub classifies the profile as Mid / Focused / Consumer Tilt.

The largest disclosed positions as of Q2 2026 were PDD ($865.66M), FUTU ($69.40M), PONY ($52.39M). By sector, the heaviest allocations are Consumer Discretionary 71.7%, Financials 15.3%. Versus the prior quarter, allocation shifted toward Health Care (+4.3pp) and away from Consumer Discretionary (-0.8pp), Technology (-1.7pp).

Versus the prior quarter, HSG Holding Ltd opened 0 new positions, trimmed 2 and fully exited 2, a turnover rate of 19.0% of positions. The portfolio's overlap with the prior quarter was 95% of names.

The largest new positions opened in Q2 2026 were GYRE ($24.71M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

  • GYRE GYRE THERAPEUTICS INC · $24.71M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest HSG Holding Ltd buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

HSG Holding Ltd is an SEC-registered 13F filer. As of Q2 2026 it reported 20 US equity positions with a combined value of $1.20B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 20 positions · $1.20B reported value (Q2 2026)
  • Top 10 holdings = 97.2% of reported value
  • Largest position: PDD (PDD HOLDINGS INC) at 72.3%
  • Average position size: $59.85M

Sector Tilt

  • Consumer Discretionary 74.4%
  • Financials 12.0%
  • Information Technology 6.4%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 1 new, 1 reduced, 1 exited
  • 18 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall Direction and Market View: The fund maintains a conservative stance with a slight preference for consumer discretionary and financials sectors, as indicated by the highest weights in PDD Holdings Inc. and Futu Holdings Ltd. The addition of GYRE Therapeutics Inc. suggests a willingness to explore health care, possibly indicating a slight shift towards growth sectors. 2. Key Moves: - Added: GYRE Therapeutics Inc. (Health Care) with 2.06% of the portfolio. This is a new position, indicating a potential interest in biotechnology or pharmaceuticals. - No Change: The fund held its positions steady in the top holdings, with no significant additions or reductions, reflecting a wait-and-see approach. - No Reductions: There were no holdings reduced or removed, which suggests a confidence in the current portfolio composition. 3. Portfolio Structure: - Passive/Active: The portfolio appears to be more passive, with a consistent hold strategy across the top holdings. - Sector Bias: The fund has a sector bias towards consumer discretionary and financials, with a smaller allocation to technology and health care. - Risk Appetite: The risk appetite seems moderate, as there were no aggressive moves and the fund maintained a conservative stance with a focus on stable sectors. 4. Per-Holding One-Liner: - PDD: Online retailer and marketplace operator; 'unverified' - FUTU: Financial technology company providing trading and investment services; 'unverified' - PONY: AI company specializing in autonomous driving and robotics; 'unverified' - CRCL: Internet-based financial services company; 'unverified' - BEKE: Financial services company offering wealth management and investment products; 'unverified' - GYRE: Biotechnology company focused on drug development; 'unverified' - BZ: Online education platform; 'unverified' - AVBP: Biotechnology company focusing on developing novel therapies; 'unverified' - DDL: Online food delivery service; 'unverified' - GPCR: Biotechnology company developing treatments for central nervous system disorders; 'unverified' 5. One-Sentence Style Summary: The HSG Holding Ltd fund maintained a conservative approach with a slight sector shift towards health care, while holding steady in its top consumer discretionary and financials holdings.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sector Allocation

Financials 15.3%
Technology 6.2%
Other 0.2%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 11.35M $865.66M 69.64%
69.64%
Hold
2 740.35K $69.40M 5.58%
5.58%
Hold
3 7.54M $52.39M 4.21%
4.21%
Hold
4 7.05M $45.99M 3.70%
3.70%
Hold
5 669.20K $41.91M 3.37%
3.37%
Hold
6 1.94M $28.17M 2.27%
2.27%
Hold
7 3.75M $24.71M 1.99%
1.99%
New
8 1.90M $24.45M 1.97%
1.97%
Hold
9 663.31K $23.04M 1.85%
1.85%
Hold
10 10.09M $19.48M 1.57%
1.57%
Hold
11 266.06K $14.28M 1.15%
1.15%
Hold
12 474.90K $7.57M 0.61%
0.61%
Hold
13 4.83M $5.66M 0.46%
0.46%
Hold
14 1.34M $5.64M 0.45%
0.45%
Hold
15 2.90M $5.54M 0.45%
0.45%
Hold
16 293.73K $4.66M 0.38%
0.38%
Hold
17 152.30K $2.14M 0.17%
0.17%
Hold
18 350.43K $1.12M 0.09%
0.09%
Hold
19 1.42M $937.51K 0.07%
0.07%
Hold
20 21.21K $177.54K 0.01%
0.01%
Hold
21 229.47K $121.62K 0.01%
0.01%
Reduce

FAQ

What did HSG Holding Ltd buy in 2026-Q2?

In its 2026-Q2 13F filing, HSG Holding Ltd reported 21 equity positions worth $1.24B in aggregate; its largest disclosed positions were PDD ($865.66M), FUTU ($69.40M), PONY ($52.39M).

How large is HSG Holding Ltd's portfolio?

HSG Holding Ltd reported $1.24B of long equity holdings across 21 positions as of 2026-Q2. Top-10 holdings account for 96.2% of reported value.

What is HSG Holding Ltd's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Consumer Tilt, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/hsg-holding/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →